Advanced Search

Journal of Traditional Chinese Medicine >

2026 , Vol. 46 >Issue 4: 779 - 787

DOI: https://doi.org/10.19852/j.cnki.jtcm.2026.04.001

Original Articles

Paeonol’s protective effects on H9C2 cells against hypoxia/ reoxygenation injury through the hypoxia-inducible factor 1-alpha/B-cell lymphoma-2/adenovirus E1B 19 kDa interacting protein 3 signaling pathway

  • ZHAO Chengguo ,
  • YIN Meifang ,
  • ZHOU Menghan ,
  • QIN Shuzhi
Expand
  • College of Life Science, Zhuhai College of Science and Technology, Zhuhai 519041, China

Received date: 2025-08-19

  Accepted date: 2026-01-30

  Online published: 2026-08-08

Supported by

Characteristic Innovation Project of Ordinary Colleges and Universities in Guangdong: Exploring the Mechanism of Paeoniflorin Against Myocardial Ischemia-reperfusion Injury Based on the Phosphatase and Tensin Homolog-induced Putative Kinase 1/Parkin Signaling Pathway(2018KTSCX307);Research Capacity Enhancement Project for Key Construction Disciplines of Guangdong Province: Study on the Pharmacological Effects and Molecular Mechanisms of Traditional Chinese Medicine Against Atherosclerosis Based on the Theory of "Li Shi Hua Zhuo"(2025ZDJS115);Tri-level Talents Development Project of Zhuhai College of Science and Technology

Fold

Abstract

OBJECTIVE: To elucidate the cytoprotective capacity of paeonol (PAE) against hypoxia/reoxygenation (H/R) injury in H9C2 cardiomyoblasts and to clarify its regulatory effects on the hypoxia-inducible factor 1-alpha (HIF-1α) and B-cell lymphoma-2/adenovirus E1B 19 kDa interacting protein 3 (BNIP3) signaling axis governing autophagy and apoptosis.

METHODS: H9C2 cells were exposed to a 12-h hypoxia condition followed by a 12-h reoxygenation regimen to simulate myocardial ischemia-reperfusion injury (MIRI). PAE pretreatment (10 μmol/L) was administered to cells before the H/R procedure. The viability of cells was determined using the cell counting kit-8 assay, whereas apoptotic rates were quantified via flow cytometry. Reactive oxygen species (ROS) levels were assayed by 2',7'-dichlorodihydrofluorescein diacetate fluorescence staining. Western blotting was conducted to assess protein expression, including cleaved caspase-3, and the ratio of Bcl-2-associated X protein to B-cell lymphoma 2 (Bax/Bcl-2), as well as microtubule- associated protein 1 light chain 3 (LC3) and sequestosome-1 (p62), along with components of the HIF-1α/BNIP3 signaling pathway. Autophagosomes were visualized by transmission electron microscopy. To elucidate the regulatory mechanisms, siRNA was used to knockdown HIF-1α expression, while the autophagy inhibitor 3-methyladenine (3-MA) was employed as a functional intervention.

RESULTS: PAE significantly improved cell viability following H/R treatment and inhibited apoptosis, as indicated by a reduction in cleaved caspase-3 levels and a decreased Bax/Bcl-2 ratio, along with diminished intracellular ROS levels. PAE treatment enhanced autophagosome formation and increased LC3-II levels, suggesting enhanced autophagic flux. Additionally, PAE upregulated the expression of HIF-1α and BNIP3. Silencing HIF-1α or inhibiting autophagy with 3-MA reversed the protective effects of PAE on autophagic flux, apoptosis, and cell viability.

CONCLUSION: PAE protects H9C2 cells against H/R injury by promoting autophagy and inhibiting apoptosis, mediated through the upregulation of the HIF-1α/BNIP3 signaling pathway. These observations highlight the therapeutic implications of PAE for MIRI, particularly through targeting the HIF-1α/BNIP3 axis.

Key words： paeonol; hypoxia-inducible factor 1, alpha subunit; membrane proteins; hypoxia/reoxygenation; H9C2 cells

Cite this article

ZHAO Chengguo , YIN Meifang , ZHOU Menghan , QIN Shuzhi . Paeonol’s protective effects on H9C2 cells against hypoxia/ reoxygenation injury through the hypoxia-inducible factor 1-alpha/B-cell lymphoma-2/adenovirus E1B 19 kDa interacting protein 3 signaling pathway[J]. Journal of Traditional Chinese Medicine, 2026 , 46(4) : 779 -787 . DOI: 10.19852/j.cnki.jtcm.2026.04.001

References

1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 2022; 80: 2361-71.
2. Zhu M, Li Y, Xu Q, Wang W, Liu Y, Liu Y. Acute myocardial infarction: molecular pathogenesis, diagnosis, and clinical management. Med Comm (2020) 2025; 6: e70418.
3. Fede MS, Daziani G, Tavoletta F, et al. Myocardial ischemia/reperfusion injury: molecular insights, forensic perspectives, and therapeutic horizons. Cells 2025; 14: 1509.
4. Juricic S, Klac J, Stojkovic S, et al. Molecular and cellular mechanisms of myocardial ischemia and reperfusion injury: a narrative review. Cells 2026; 15: 265.
5. He J, Liu D, Zhao L, et al. Myocardial ischemia/reperfusion injury: mechanisms of injury and implications for management (review). Exp Ther Med 2022; 23: 430.
6. Zhu Y, Liu F, Jian F, Rong Y. Recent progresses in the late stages of autophagy. Cell Insight 2024; 3: 100152.
7. Lin PW, Chu ML, Liu HS. Autophagy and metabolism. Kaohsiung J Med Sci 2021; 37: 12-9.
8. Zhou G, Zhang L, Bai W, et al. Devil or angel: a review of autophagy in ischemia-reperfusion injury. Medicine (Baltimore) 2025; 104: e45330.
9. Shen L, Zhu Y, Chen Z, Shen F, Yu W, Zhang L. Isoliquiritigenin attenuates myocardial ischemia reperfusion through autophagy activation mediated by AMPK/mTOR/ULK1 signaling. BMC Cardiovasc Disord 2024; 24: 415.
10. Xie M, Cho GW, Kong Y, et al. Activation of autophagic flux blunts cardiac ischemia/reperfusion injury. Circ Res 2021; 129: 435-50.
11. Liu XW, Lu MK, Zhong HT, Wang LH, Fu YP. Panax notoginseng saponins attenuate myocardial ischemia-reperfusion injury through the HIF-1α/BNIP3 pathway of autophagy. J Cardiovasc Pharmacol 2019; 73: 92-9.
12. Zhu N, Li J, Li Y, et al. Berberine protects against simulated ischemia/reperfusion injury-induced H9C2 cardiomyocytes apoptosis in vitro and myocardial ischemia/reperfusion-induced apoptosis in vivo by regulating the mitophagy-mediated HIF-1α/BNIP3 pathway. Front Pharmacol 2020; 11: 367.
13. Li S, Jiang J, Fang J, et al. Naringin protects H9C 2 cardiomyocytes from chemical hypoxia-induced injury by promoting the autophagic flux via the activation of the HIF-1α/BNIP3 signaling pathway. Int J Mol Med 2021; 47: 102.
14. Vellasamy S, Murugan D, Abas R, Alias A, Seng WY, Woon CK. Biological activities of paeonol in cardiovascular diseases: a review. Molecules 2021; 26: 4976..
15. Ma X, Zhao X, Yang Y, et al. Paeonol inhibits NETs-mediated foam cell inflammation through the CitH3/NLRP3/caspase-1 signaling pathway in atherosclerosis. Int Immunopharmacol 2025; 151: 114340.
16. Wang Y, Li BS, Zhang ZH, et al. Paeonol repurposing for cancer therapy: from mechanism to clinical translation. Biomed Pharmacother 2023; 165: 115277.
17. Zheng J, Mao Z, Zhang J, Jiang L, Wang N. Paeonol pretreatment attenuates anoxia-reoxygenation induced injury in cardiac myocytes via a BRCA1 dependent pathway. Chem Pharm Bull (Tokyo) 2020; 68: 1163-9.
18. Tsai CF, Su HH, Chen KM, et al. Paeonol protects against myocardial ischemia/reperfusion-induced injury by mediating apoptosis and autophagy crosstalk. Front Pharmacol 2021; 11: 586498.
19. Qi C, Zhang J, Chen X, et al. Hypoxia stimulates neural stem cell proliferation by increasing HIF-1α expression and activating Wnt/β-catenin signaling. Cell Mol Biol (Noisy-le-grand) 2017; 63: 12-9.
20. Unnisa A, Greig NH, Kamal MA. Inhibition of caspase 3 and caspase 9 mediated apoptosis: a multimodal therapeutic target in traumatic brain injury. Curr Neuropharmacol 2023; 21: 1001-12.
21. Li Z, Xiao G, Wang H, He S, Zhu Y. A preparation of Ginkgo biloba L. leaves extract inhibits the apoptosis of hippocampal neurons in post-stroke mice via regulating the expression of Bax/Bcl-2 and Caspase-3. J Ethnopharmacol 2021; 280: 114481.
22. Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis 2020; 1866: 165768.
23. Zhang Y, Liu D, Hu H, Zhang P, Xie R, Cui W. HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother 2019; 120: 109464.
24. Zhang S, Yan F, Luan F, et al. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury. Phytomedicine 2024; 129: 155649.
25. Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab 2024; 35: 219-34.
26. Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 2020; 17: 773-89.
27. Zhang H, Hu H, Zhai C, Jing L, Tian H. Cardioprotective strategies after ischemia-reperfusion injury. Am J Cardiovasc Drugs 2024; 24: 5-18.
28. Liu Y, Wu Z, Jin X, et al. Paeonol improves cardiac remodelling in MI mice by suppressing NOX2 mRNA expression to mitigate oxidative stress and mitochondrial dysfunction. J Cell Mol Med 2025; 29: e70563.
29. Wu M, Yu Z, Li X, et al. Paeonol for the treatment of atherosclerotic cardiovascular disease: a pharmacological and mechanistic overview. Front Cardiovasc Med 2021; 8: 690116.
30. Li X, Hu H, Yin J, Cheng W, Shi Y, Wang Y. Paeonol can improve hypoxic-induced H9c2 cells injury and ion channel activity by up-regulating the expression of CKIP-1. Tissue Cell 2024; 88: 102371.
31. Korshunova AY, Blagonravov ML, Neborak EV, et al. BCL2-regulated apoptotic process in myocardial ischemia-reperfusion injury (Review). Int J Mol Med 2021; 47: 23-36.
32. McComb S, Chan PK, Guinot A, et al. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7. Sci Adv 2019; 5: eaau9433.
33. Gong G, Wan W, Zhang X, Chen X, Yin J. Management of ROS and regulatory cell death in myocardial ischemia-reperfusion injury. Mol Biotechnol 2025; 67: 1765-83.
34. Mokhtari B, Badalzadeh R. The potentials of distinct functions of autophagy to be targeted for attenuation of myocardial ischemia/reperfusion injury in preclinical studies: an up-to-date review. J Physiol Biochem 2021; 77: 377-404.
35. Xu H, Cheng J, He F. Cordycepin alleviates myocardial ischemia/reperfusion injury by enhancing autophagy via AMPK-mTOR pathway. J Physiol Biochem 2022; 78: 401-13.
36. Qu X, Chen X, Shi Q, Wang X, Wang D, Yang L. Resveratrol alleviates ischemia/reperfusion injury of diabetic myocardium via inducing autophagy. Exp Ther Med 2019; 18: 2719-25.
37. Chen L, Lv Y, Wu H, et al. Gastrodin exerts perioperative myocardial protection by improving mitophagy through the PINK1/Parkin pathway to reduce myocardial ischemia-reperfusion injury. Phytomedicine 2024; 133: 155900.
38. Wu Y, Zhang H, Wang Y, Zhang Y, Hong Z, Wang D. Sephin 1 enhances integrated stress response and autophagy to alleviate myocardial ischemia-reperfusion injury in mice. Biomed Pharmacother 2024; 176: 116869.
39. He H, Liu P, Li P. Dexmedetomidine ameliorates cardiac ischemia/reperfusion injury by enhancing autophagy through activation of the AMPK/SIRT3 pathway. Drug Des Devel Ther 2023; 17: 3205-18.
40. Aljakna Khan A, Sabatasso S. Autophagy in myocardial ischemia and ischemia/reperfusion. Cardiovasc Pathol 2025; 74: 107691.
41. Shang JN, Yu CG, Li R, et al. The nonautophagic functions of autophagy-related proteins. Autophagy 2024; 20: 720-34.
42. Alcober-Boquet L, Zang T, Pietsch L, et al. The PB1 and the ZZ domain of the autophagy receptor p62/SQSTM1 regulate the interaction of p62/SQSTM1 with the autophagosome protein LC3B. Protein Sci 2024; 33: e4840.
43. Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front Pharmacol 2020; 11: 408.
44. Youle R, Narendra D. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12: 9-14.
45. Sousa Fialho MDL, Abd Jamil AH, Stannard GA, Heather LC. Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis 2019; 1865: 831-43.
46. Carmichael E, Reme AS, Bosco PJ, et al. Biological regulation of HIF-1α and its role in therapeutic angiogenesis for treatment of ischemic cardiovascular disease. Int J Mol Sci 2025; 26: 11236.
47. Alanova P, Alan L, Opletalova B, et al. HIF-1α limits myocardial infarction by promoting mitophagy in mouse hearts adapted to chronic hypoxia. Acta Physiol (Oxf) 2024; 240: e14202.
48. Gong N, Yang X, Li X, et al. MicroRNA-590-3p relieves hypoxia/reoxygenation induced cardiomyocytes apoptosis and autophagy by targeting HIF-1α. Exp Ther Med 2021; 22: 1077.
49. Fu ZJ, Wang ZY, Xu L, et al. HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol 2020; 36: 101671.
50. Cheng S, Jian C, Yufang Z, et al. Protective effect of Dan Ze mixture against lipotoxic cardiomyopathy through activating B-cell lymphoma-2 adenovirus E1B 19 kDa-interacting protein 3/mitophagy signaling pathway. J Tradit Chin Med 2025; 45: 538-51.
51. Zhang YN, Pang YX, Liu DW, Hu HJ, Xie RQ, Cui W. JMJD 5 attenuates oxygen-glucose deprivation and reperfusion-induced injury in cardiomyocytes through regulation of HIF-1α-BNIP3. Kaohsiung J Med Sci 2022; 38: 38-48.
Options
Outlines

/

〈 〉